Direktorat Registrasi ObatValid

QUETIAPINE FUMARATE

BPOM Number: GKL2043501014A1
Approved: 27 December 2025
Expiry: 19 March 2030
Form: TABLET PELEPASAN LAMBAT

About This Registration

QUETIAPINE FUMARATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2043501014A1. Its current registration status is Valid, with the licence valid until 19 March 2030. The product is registered to AMAROX PHARMA GLOBAL - INDONESIA. BPOM first approved this registration in December 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: newaero
Packaging: DUS, 3 STRIP @ 10 TABLET PELEPASAN LAMBAT
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

AMAROX PHARMA GLOBAL - INDONESIA
KAB. BEKASI
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

AMAROX PHARMA GLOBAL - INDONESIA
KAB. BEKASI
primary
View profile →

Ingredients (1)

QUETIAPINE FUMARATE

Market Intelligence

Owner Portfolio: AMAROX PHARMA GLOBAL - INDONESIA holds 234 BPOM registrations
Manufacturer Scale: AMAROX PHARMA GLOBAL - INDONESIA produces 234 registered products
Registration Age: Registered for 8 months

FDA Cross-Reference

via openFDA

Generic Name: QUETIAPINE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?